June 2021
Volume 62, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2021
Longitudinal Changes in Microaneurysm Count and the Correlation with Leakage Index and Leakage Patterns in Diabetic Retinopathy on Ultra-widefield Fluorescein Angiography Following Intravitreal Aflibercept in the PRIME study
Author Affiliations & Notes
  • Margaret O'Connell
    Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio, United States
  • Duriye Damla Sevgi
    Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio, United States
  • Charles Clifton Wykoff
    Retina Consultants of Texas, Houston, Texas, United States
  • Hannah Yu
    Retina Consultants of Texas, Houston, Texas, United States
  • Jenna Hach
    Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio, United States
  • Sunil K. Srivastava
    Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio, United States
  • Jamie Reese
    Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio, United States
  • Justis P Ehlers
    Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio, United States
  • Footnotes
    Commercial Relationships   Margaret O'Connell, None; Duriye Damla Sevgi, None; Charles Wykoff, Adverum (F), Alimera Sciences (C), Allegro (C), Allergan (F), Alynylam (C), Apellis (F), Bayer (C), Clearside (F), D.O.R.C (C), Eyepoint (F), Genentech/Roche (F), Kodiak (C), Neurotech (F), Notal Vision (C), Novartis (F), ONL Therapeutics (C), Opthea (F), PolyPhotonix (C), RecensMedical (C), Regeneron (F), Regeneron (C), Regenxbio (F), Regenxbio (C), Samsung (F), Santen (F); Hannah Yu, None; Jenna Hach, None; Sunil K. Srivastava, Abbvie (C), Allergan (C), Allergan (F), Eyepoint (C), Eyepoint (F), Eyevensys (C), Eyevensys (F), Gilead (C), Leica (P), Novartis (C), Regeneron (C), Regeneron (F), Santen (F), Zeiss (C); Jamie Reese, None; Justis Ehlers, Adverum (C), Aerpio (F), Aerpio (C), Alcon (F), Alcon (C), Allegro (C), Allergan (F), Allergan (C), Boehringer-Ingelheim (F), Genentech (F), Genentech/Roche (C), Leica (P), Leica (C), Novartis (F), Novartis (C), Regeneron (F), Regeneron (C), Santen (C), Stealth (C), Thrombogenics/Oxurion (F), Thrombogenics/Oxurion (C), Zeiss (C)
  • Footnotes
    Support  RPB Cole Eye Institutional Grant, NIH/NEI K23-EY022947
Investigative Ophthalmology & Visual Science June 2021, Vol.62, 1094. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Margaret O'Connell, Duriye Damla Sevgi, Charles Clifton Wykoff, Hannah Yu, Jenna Hach, Sunil K. Srivastava, Jamie Reese, Justis P Ehlers; Longitudinal Changes in Microaneurysm Count and the Correlation with Leakage Index and Leakage Patterns in Diabetic Retinopathy on Ultra-widefield Fluorescein Angiography Following Intravitreal Aflibercept in the PRIME study. Invest. Ophthalmol. Vis. Sci. 2021;62(8):1094.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To quantify longitudinal changes in microaneurysm (MA) count on ultra-widefield fluorescein angiography (UWFA) and their correlation with panretinal leakage index (PLI) in eyes with diabetic retinopathy (DR) being treated with as needed intravitreal aflibercept (IAI) guided by real-time DR severity score (DRSS) and PLI evaluations.

Methods : The PRIME study is a randomized prospective clinical trial comparing real-time DRSS-guided IAI treatment to real-time PLI-guided IAI treatment. 41 eyes with DRSS of 47 to 71 were randomized 1:1 to receive as needed IAI as determined by DRSS (DRSS cohort, n=21) or PLI (PLI cohort, n=20). UWFA and fundus photos were obtained monthly. UWFA images were analyzed in real-time with an automated analysis platform to quantify MA count and PLI with manual validation. Two trained readers evaluated the baseline UWFA images and classified them as having predominantly perivascular leakage or non-perivascular (including focal) leakage.

Results : Mean MA counts and PLI indices did not differ significantly at baseline between the DRSS cohort and the PLI cohort, with 839 ± 307 and 884 ± 331 MAs (P=0.66), respectively. At year 1, the MA count improved significantly to 662±334 (P=0.03) in the DRSS cohort and 744 ± 526 (P=0.05) in the PLI cohort. Total mean MA and PLIs were positively correlated at both month six (r=0.35, P=0.03) and year one (r=0.46, P=0.007).

Eyes with predominant perivascular leakage (n=19) demonstrated a larger but non-significant reduction in mean MA count (-210) compared to eyes with predominant non-perivascular leakage (n=14, -109, P=0.28).

Conclusions : Both DRSS and PLI cohorts demonstrated a significant decrease in MA count after one year of image-guided IAI treatment. Total mean MA count and total mean PLIs were correlated at month six and year one. Eyes with predominant perivascular leakage at baseline had a nonsignificant greater reduction in MA count. Further research in larger datasets is needed to further explore the potential association of MA reduction with underlying leakage patterns and whether this may be indicative of specific active pathways.

This is a 2021 ARVO Annual Meeting abstract.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×